ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Varicella Attenuated Live Vaccination Market Research Report 2025
Published Date: January 2025
|
Report Code: QYRE-Auto-16E13152
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Varicella Attenuated Live Vaccination Market Research Report 2023
BUY CHAPTERS

Global Varicella Attenuated Live Vaccination Market Research Report 2025

Code: QYRE-Auto-16E13152
Report
January 2025
Pages:80
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
BCHT
Shanghai Institute
GSK
Keygen
Green Cross
Biken
Shanghai Rongsheng Biotech
Changsheng
Merck

Varicella Attenuated Live Vaccination Market Size

The global market for Varicella Attenuated Live Vaccination was valued at US$ 2708 million in the year 2024 and is projected to reach a revised size of US$ 3298 million by 2031, growing at a CAGR of 2.9% during the forecast period.

Varicella Attenuated Live Vaccination Market

Varicella Attenuated Live Vaccination Market

A live attenuated varicella vaccine, derived from the Oka strain of VZV has clinical efficacy for the prevention of varicella.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Varicella Attenuated Live Vaccination, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Varicella Attenuated Live Vaccination.
The Varicella Attenuated Live Vaccination market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Varicella Attenuated Live Vaccination market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Varicella Attenuated Live Vaccination manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Varicella Attenuated Live Vaccination Market Report

Report Metric Details
Report Name Varicella Attenuated Live Vaccination Market
Accounted market size in year US$ 2708 million
Forecasted market size in 2031 US$ 3298 million
CAGR 2.9%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Children
  • Adults
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Merck, BCHT, Shanghai Institute, GSK, Keygen, Green Cross, Biken, Shanghai Rongsheng Biotech, Changsheng
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Varicella Attenuated Live Vaccination manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Varicella Attenuated Live Vaccination in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Varicella Attenuated Live Vaccination Market growing?

Ans: The Varicella Attenuated Live Vaccination Market witnessing a CAGR of 2.9% during the forecast period 2025-2031.

What is the Varicella Attenuated Live Vaccination Market size in 2031?

Ans: The Varicella Attenuated Live Vaccination Market size in 2031 will be US$ 3298 million.

Who are the main players in the Varicella Attenuated Live Vaccination Market report?

Ans: The main players in the Varicella Attenuated Live Vaccination Market are Merck, BCHT, Shanghai Institute, GSK, Keygen, Green Cross, Biken, Shanghai Rongsheng Biotech, Changsheng

What are the Application segmentation covered in the Varicella Attenuated Live Vaccination Market report?

Ans: The Applications covered in the Varicella Attenuated Live Vaccination Market report are Children, Adults

What are the Type segmentation covered in the Varicella Attenuated Live Vaccination Market report?

Ans: The Types covered in the Varicella Attenuated Live Vaccination Market report are Monovalent Vaccine, Combination Vaccine

Recommended Reports

Live & Attenuated Vaccines

Preventable & Pediatric Vaccines

Combination & Multivalent Vaccines

1 Varicella Attenuated Live Vaccination Market Overview
1.1 Product Definition
1.2 Varicella Attenuated Live Vaccination by Type
1.2.1 Global Varicella Attenuated Live Vaccination Market Value Comparison by Type (2024 VS 2031)
1.2.2 Monovalent Vaccine
1.2.3 Combination Vaccine
1.3 Varicella Attenuated Live Vaccination by Application
1.3.1 Global Varicella Attenuated Live Vaccination Market Value by Application (2024 VS 2031)
1.3.2 Children
1.3.3 Adults
1.4 Global Varicella Attenuated Live Vaccination Market Size Estimates and Forecasts
1.4.1 Global Varicella Attenuated Live Vaccination Revenue 2020-2031
1.4.2 Global Varicella Attenuated Live Vaccination Sales 2020-2031
1.4.3 Global Varicella Attenuated Live Vaccination Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Varicella Attenuated Live Vaccination Market Competition by Manufacturers
2.1 Global Varicella Attenuated Live Vaccination Sales Market Share by Manufacturers (2020-2025)
2.2 Global Varicella Attenuated Live Vaccination Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Varicella Attenuated Live Vaccination Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Varicella Attenuated Live Vaccination, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Varicella Attenuated Live Vaccination, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Varicella Attenuated Live Vaccination, Product Type & Application
2.7 Global Key Manufacturers of Varicella Attenuated Live Vaccination, Date of Enter into This Industry
2.8 Global Varicella Attenuated Live Vaccination Market Competitive Situation and Trends
2.8.1 Global Varicella Attenuated Live Vaccination Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Varicella Attenuated Live Vaccination Players Market Share by Revenue
2.8.3 Global Varicella Attenuated Live Vaccination Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Varicella Attenuated Live Vaccination Market Scenario by Region
3.1 Global Varicella Attenuated Live Vaccination Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Varicella Attenuated Live Vaccination Sales by Region: 2020-2031
3.2.1 Global Varicella Attenuated Live Vaccination Sales by Region: 2020-2025
3.2.2 Global Varicella Attenuated Live Vaccination Sales by Region: 2026-2031
3.3 Global Varicella Attenuated Live Vaccination Revenue by Region: 2020-2031
3.3.1 Global Varicella Attenuated Live Vaccination Revenue by Region: 2020-2025
3.3.2 Global Varicella Attenuated Live Vaccination Revenue by Region: 2026-2031
3.4 North America Varicella Attenuated Live Vaccination Market Facts & Figures by Country
3.4.1 North America Varicella Attenuated Live Vaccination Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Varicella Attenuated Live Vaccination Sales by Country (2020-2031)
3.4.3 North America Varicella Attenuated Live Vaccination Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Varicella Attenuated Live Vaccination Market Facts & Figures by Country
3.5.1 Europe Varicella Attenuated Live Vaccination Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Varicella Attenuated Live Vaccination Sales by Country (2020-2031)
3.5.3 Europe Varicella Attenuated Live Vaccination Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Varicella Attenuated Live Vaccination Market Facts & Figures by Region
3.6.1 Asia Pacific Varicella Attenuated Live Vaccination Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Varicella Attenuated Live Vaccination Sales by Region (2020-2031)
3.6.3 Asia Pacific Varicella Attenuated Live Vaccination Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Varicella Attenuated Live Vaccination Market Facts & Figures by Country
3.7.1 Latin America Varicella Attenuated Live Vaccination Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Varicella Attenuated Live Vaccination Sales by Country (2020-2031)
3.7.3 Latin America Varicella Attenuated Live Vaccination Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Varicella Attenuated Live Vaccination Market Facts & Figures by Country
3.8.1 Middle East and Africa Varicella Attenuated Live Vaccination Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Varicella Attenuated Live Vaccination Sales by Country (2020-2031)
3.8.3 Middle East and Africa Varicella Attenuated Live Vaccination Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Varicella Attenuated Live Vaccination Sales by Type (2020-2031)
4.1.1 Global Varicella Attenuated Live Vaccination Sales by Type (2020-2025)
4.1.2 Global Varicella Attenuated Live Vaccination Sales by Type (2026-2031)
4.1.3 Global Varicella Attenuated Live Vaccination Sales Market Share by Type (2020-2031)
4.2 Global Varicella Attenuated Live Vaccination Revenue by Type (2020-2031)
4.2.1 Global Varicella Attenuated Live Vaccination Revenue by Type (2020-2025)
4.2.2 Global Varicella Attenuated Live Vaccination Revenue by Type (2026-2031)
4.2.3 Global Varicella Attenuated Live Vaccination Revenue Market Share by Type (2020-2031)
4.3 Global Varicella Attenuated Live Vaccination Price by Type (2020-2031)
5 Segment by Application
5.1 Global Varicella Attenuated Live Vaccination Sales by Application (2020-2031)
5.1.1 Global Varicella Attenuated Live Vaccination Sales by Application (2020-2025)
5.1.2 Global Varicella Attenuated Live Vaccination Sales by Application (2026-2031)
5.1.3 Global Varicella Attenuated Live Vaccination Sales Market Share by Application (2020-2031)
5.2 Global Varicella Attenuated Live Vaccination Revenue by Application (2020-2031)
5.2.1 Global Varicella Attenuated Live Vaccination Revenue by Application (2020-2025)
5.2.2 Global Varicella Attenuated Live Vaccination Revenue by Application (2026-2031)
5.2.3 Global Varicella Attenuated Live Vaccination Revenue Market Share by Application (2020-2031)
5.3 Global Varicella Attenuated Live Vaccination Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Company Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Varicella Attenuated Live Vaccination Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Merck Varicella Attenuated Live Vaccination Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 BCHT
6.2.1 BCHT Company Information
6.2.2 BCHT Description and Business Overview
6.2.3 BCHT Varicella Attenuated Live Vaccination Sales, Revenue and Gross Margin (2020-2025)
6.2.4 BCHT Varicella Attenuated Live Vaccination Product Portfolio
6.2.5 BCHT Recent Developments/Updates
6.3 Shanghai Institute
6.3.1 Shanghai Institute Company Information
6.3.2 Shanghai Institute Description and Business Overview
6.3.3 Shanghai Institute Varicella Attenuated Live Vaccination Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Shanghai Institute Varicella Attenuated Live Vaccination Product Portfolio
6.3.5 Shanghai Institute Recent Developments/Updates
6.4 GSK
6.4.1 GSK Company Information
6.4.2 GSK Description and Business Overview
6.4.3 GSK Varicella Attenuated Live Vaccination Sales, Revenue and Gross Margin (2020-2025)
6.4.4 GSK Varicella Attenuated Live Vaccination Product Portfolio
6.4.5 GSK Recent Developments/Updates
6.5 Keygen
6.5.1 Keygen Company Information
6.5.2 Keygen Description and Business Overview
6.5.3 Keygen Varicella Attenuated Live Vaccination Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Keygen Varicella Attenuated Live Vaccination Product Portfolio
6.5.5 Keygen Recent Developments/Updates
6.6 Green Cross
6.6.1 Green Cross Company Information
6.6.2 Green Cross Description and Business Overview
6.6.3 Green Cross Varicella Attenuated Live Vaccination Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Green Cross Varicella Attenuated Live Vaccination Product Portfolio
6.6.5 Green Cross Recent Developments/Updates
6.7 Biken
6.7.1 Biken Company Information
6.7.2 Biken Description and Business Overview
6.7.3 Biken Varicella Attenuated Live Vaccination Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Biken Varicella Attenuated Live Vaccination Product Portfolio
6.7.5 Biken Recent Developments/Updates
6.8 Shanghai Rongsheng Biotech
6.8.1 Shanghai Rongsheng Biotech Company Information
6.8.2 Shanghai Rongsheng Biotech Description and Business Overview
6.8.3 Shanghai Rongsheng Biotech Varicella Attenuated Live Vaccination Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Shanghai Rongsheng Biotech Varicella Attenuated Live Vaccination Product Portfolio
6.8.5 Shanghai Rongsheng Biotech Recent Developments/Updates
6.9 Changsheng
6.9.1 Changsheng Company Information
6.9.2 Changsheng Description and Business Overview
6.9.3 Changsheng Varicella Attenuated Live Vaccination Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Changsheng Varicella Attenuated Live Vaccination Product Portfolio
6.9.5 Changsheng Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Varicella Attenuated Live Vaccination Industry Chain Analysis
7.2 Varicella Attenuated Live Vaccination Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Varicella Attenuated Live Vaccination Production Mode & Process Analysis
7.4 Varicella Attenuated Live Vaccination Sales and Marketing
7.4.1 Varicella Attenuated Live Vaccination Sales Channels
7.4.2 Varicella Attenuated Live Vaccination Distributors
7.5 Varicella Attenuated Live Vaccination Customer Analysis
8 Varicella Attenuated Live Vaccination Market Dynamics
8.1 Varicella Attenuated Live Vaccination Industry Trends
8.2 Varicella Attenuated Live Vaccination Market Drivers
8.3 Varicella Attenuated Live Vaccination Market Challenges
8.4 Varicella Attenuated Live Vaccination Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
BCHT
Shanghai Institute
GSK
Keygen
Green Cross
Biken
Shanghai Rongsheng Biotech
Changsheng
Merck
List of Tables
 Table 1. Global Varicella Attenuated Live Vaccination Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Varicella Attenuated Live Vaccination Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Varicella Attenuated Live Vaccination Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Varicella Attenuated Live Vaccination Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Varicella Attenuated Live Vaccination Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Varicella Attenuated Live Vaccination Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Varicella Attenuated Live Vaccination Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Varicella Attenuated Live Vaccination Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Varicella Attenuated Live Vaccination, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Varicella Attenuated Live Vaccination, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Varicella Attenuated Live Vaccination, Product Type & Application
 Table 12. Global Key Manufacturers of Varicella Attenuated Live Vaccination, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Varicella Attenuated Live Vaccination by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Varicella Attenuated Live Vaccination as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Varicella Attenuated Live Vaccination Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Varicella Attenuated Live Vaccination Sales by Region (2020-2025) & (K Units)
 Table 18. Global Varicella Attenuated Live Vaccination Sales Market Share by Region (2020-2025)
 Table 19. Global Varicella Attenuated Live Vaccination Sales by Region (2026-2031) & (K Units)
 Table 20. Global Varicella Attenuated Live Vaccination Sales Market Share by Region (2026-2031)
 Table 21. Global Varicella Attenuated Live Vaccination Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Varicella Attenuated Live Vaccination Revenue Market Share by Region (2020-2025)
 Table 23. Global Varicella Attenuated Live Vaccination Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Varicella Attenuated Live Vaccination Revenue Market Share by Region (2026-2031)
 Table 25. North America Varicella Attenuated Live Vaccination Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Varicella Attenuated Live Vaccination Sales by Country (2020-2025) & (K Units)
 Table 27. North America Varicella Attenuated Live Vaccination Sales by Country (2026-2031) & (K Units)
 Table 28. North America Varicella Attenuated Live Vaccination Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Varicella Attenuated Live Vaccination Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Varicella Attenuated Live Vaccination Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Varicella Attenuated Live Vaccination Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Varicella Attenuated Live Vaccination Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Varicella Attenuated Live Vaccination Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Varicella Attenuated Live Vaccination Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Varicella Attenuated Live Vaccination Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Varicella Attenuated Live Vaccination Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Varicella Attenuated Live Vaccination Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Varicella Attenuated Live Vaccination Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Varicella Attenuated Live Vaccination Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Varicella Attenuated Live Vaccination Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Varicella Attenuated Live Vaccination Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Varicella Attenuated Live Vaccination Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Varicella Attenuated Live Vaccination Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Varicella Attenuated Live Vaccination Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Varicella Attenuated Live Vaccination Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Varicella Attenuated Live Vaccination Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Varicella Attenuated Live Vaccination Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Varicella Attenuated Live Vaccination Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Varicella Attenuated Live Vaccination Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Varicella Attenuated Live Vaccination Sales (K Units) by Type (2020-2025)
 Table 51. Global Varicella Attenuated Live Vaccination Sales (K Units) by Type (2026-2031)
 Table 52. Global Varicella Attenuated Live Vaccination Sales Market Share by Type (2020-2025)
 Table 53. Global Varicella Attenuated Live Vaccination Sales Market Share by Type (2026-2031)
 Table 54. Global Varicella Attenuated Live Vaccination Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Varicella Attenuated Live Vaccination Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Varicella Attenuated Live Vaccination Revenue Market Share by Type (2020-2025)
 Table 57. Global Varicella Attenuated Live Vaccination Revenue Market Share by Type (2026-2031)
 Table 58. Global Varicella Attenuated Live Vaccination Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Varicella Attenuated Live Vaccination Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Varicella Attenuated Live Vaccination Sales (K Units) by Application (2020-2025)
 Table 61. Global Varicella Attenuated Live Vaccination Sales (K Units) by Application (2026-2031)
 Table 62. Global Varicella Attenuated Live Vaccination Sales Market Share by Application (2020-2025)
 Table 63. Global Varicella Attenuated Live Vaccination Sales Market Share by Application (2026-2031)
 Table 64. Global Varicella Attenuated Live Vaccination Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Varicella Attenuated Live Vaccination Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Varicella Attenuated Live Vaccination Revenue Market Share by Application (2020-2025)
 Table 67. Global Varicella Attenuated Live Vaccination Revenue Market Share by Application (2026-2031)
 Table 68. Global Varicella Attenuated Live Vaccination Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Varicella Attenuated Live Vaccination Price (US$/Unit) by Application (2026-2031)
 Table 70. Merck Company Information
 Table 71. Merck Description and Business Overview
 Table 72. Merck Varicella Attenuated Live Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Merck Varicella Attenuated Live Vaccination Product
 Table 74. Merck Recent Developments/Updates
 Table 75. BCHT Company Information
 Table 76. BCHT Description and Business Overview
 Table 77. BCHT Varicella Attenuated Live Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. BCHT Varicella Attenuated Live Vaccination Product
 Table 79. BCHT Recent Developments/Updates
 Table 80. Shanghai Institute Company Information
 Table 81. Shanghai Institute Description and Business Overview
 Table 82. Shanghai Institute Varicella Attenuated Live Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Shanghai Institute Varicella Attenuated Live Vaccination Product
 Table 84. Shanghai Institute Recent Developments/Updates
 Table 85. GSK Company Information
 Table 86. GSK Description and Business Overview
 Table 87. GSK Varicella Attenuated Live Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. GSK Varicella Attenuated Live Vaccination Product
 Table 89. GSK Recent Developments/Updates
 Table 90. Keygen Company Information
 Table 91. Keygen Description and Business Overview
 Table 92. Keygen Varicella Attenuated Live Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Keygen Varicella Attenuated Live Vaccination Product
 Table 94. Keygen Recent Developments/Updates
 Table 95. Green Cross Company Information
 Table 96. Green Cross Description and Business Overview
 Table 97. Green Cross Varicella Attenuated Live Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Green Cross Varicella Attenuated Live Vaccination Product
 Table 99. Green Cross Recent Developments/Updates
 Table 100. Biken Company Information
 Table 101. Biken Description and Business Overview
 Table 102. Biken Varicella Attenuated Live Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Biken Varicella Attenuated Live Vaccination Product
 Table 104. Biken Recent Developments/Updates
 Table 105. Shanghai Rongsheng Biotech Company Information
 Table 106. Shanghai Rongsheng Biotech Description and Business Overview
 Table 107. Shanghai Rongsheng Biotech Varicella Attenuated Live Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Shanghai Rongsheng Biotech Varicella Attenuated Live Vaccination Product
 Table 109. Shanghai Rongsheng Biotech Recent Developments/Updates
 Table 110. Changsheng Company Information
 Table 111. Changsheng Description and Business Overview
 Table 112. Changsheng Varicella Attenuated Live Vaccination Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Changsheng Varicella Attenuated Live Vaccination Product
 Table 114. Changsheng Recent Developments/Updates
 Table 115. Key Raw Materials Lists
 Table 116. Raw Materials Key Suppliers Lists
 Table 117. Varicella Attenuated Live Vaccination Distributors List
 Table 118. Varicella Attenuated Live Vaccination Customers List
 Table 119. Varicella Attenuated Live Vaccination Market Trends
 Table 120. Varicella Attenuated Live Vaccination Market Drivers
 Table 121. Varicella Attenuated Live Vaccination Market Challenges
 Table 122. Varicella Attenuated Live Vaccination Market Restraints
 Table 123. Research Programs/Design for This Report
 Table 124. Key Data Information from Secondary Sources
 Table 125. Key Data Information from Primary Sources
 Table 126. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Varicella Attenuated Live Vaccination
 Figure 2. Global Varicella Attenuated Live Vaccination Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Varicella Attenuated Live Vaccination Market Share by Type: 2024 & 2031
 Figure 4. Monovalent Vaccine Product Picture
 Figure 5. Combination Vaccine Product Picture
 Figure 6. Global Varicella Attenuated Live Vaccination Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Varicella Attenuated Live Vaccination Market Share by Application: 2024 & 2031
 Figure 8. Children
 Figure 9. Adults
 Figure 10. Global Varicella Attenuated Live Vaccination Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Varicella Attenuated Live Vaccination Market Size (2020-2031) & (US$ Million)
 Figure 12. Global Varicella Attenuated Live Vaccination Sales (2020-2031) & (K Units)
 Figure 13. Global Varicella Attenuated Live Vaccination Average Price (US$/Unit) & (2020-2031)
 Figure 14. Varicella Attenuated Live Vaccination Report Years Considered
 Figure 15. Varicella Attenuated Live Vaccination Sales Share by Manufacturers in 2024
 Figure 16. Global Varicella Attenuated Live Vaccination Revenue Share by Manufacturers in 2024
 Figure 17. Global 5 and 10 Largest Varicella Attenuated Live Vaccination Players: Market Share by Revenue in Varicella Attenuated Live Vaccination in 2024
 Figure 18. Varicella Attenuated Live Vaccination Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 19. Global Varicella Attenuated Live Vaccination Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 20. North America Varicella Attenuated Live Vaccination Sales Market Share by Country (2020-2031)
 Figure 21. North America Varicella Attenuated Live Vaccination Revenue Market Share by Country (2020-2031)
 Figure 22. United States Varicella Attenuated Live Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 23. Canada Varicella Attenuated Live Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Europe Varicella Attenuated Live Vaccination Sales Market Share by Country (2020-2031)
 Figure 25. Europe Varicella Attenuated Live Vaccination Revenue Market Share by Country (2020-2031)
 Figure 26. Germany Varicella Attenuated Live Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. France Varicella Attenuated Live Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. U.K. Varicella Attenuated Live Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Italy Varicella Attenuated Live Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Russia Varicella Attenuated Live Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Asia Pacific Varicella Attenuated Live Vaccination Sales Market Share by Region (2020-2031)
 Figure 32. Asia Pacific Varicella Attenuated Live Vaccination Revenue Market Share by Region (2020-2031)
 Figure 33. China Varicella Attenuated Live Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Japan Varicella Attenuated Live Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. South Korea Varicella Attenuated Live Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. India Varicella Attenuated Live Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Australia Varicella Attenuated Live Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. China Taiwan Varicella Attenuated Live Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Indonesia Varicella Attenuated Live Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Thailand Varicella Attenuated Live Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Malaysia Varicella Attenuated Live Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Latin America Varicella Attenuated Live Vaccination Sales Market Share by Country (2020-2031)
 Figure 43. Latin America Varicella Attenuated Live Vaccination Revenue Market Share by Country (2020-2031)
 Figure 44. Mexico Varicella Attenuated Live Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Brazil Varicella Attenuated Live Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Argentina Varicella Attenuated Live Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Middle East and Africa Varicella Attenuated Live Vaccination Sales Market Share by Country (2020-2031)
 Figure 48. Middle East and Africa Varicella Attenuated Live Vaccination Revenue Market Share by Country (2020-2031)
 Figure 49. Turkey Varicella Attenuated Live Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Saudi Arabia Varicella Attenuated Live Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. UAE Varicella Attenuated Live Vaccination Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Global Sales Market Share of Varicella Attenuated Live Vaccination by Type (2020-2031)
 Figure 53. Global Revenue Market Share of Varicella Attenuated Live Vaccination by Type (2020-2031)
 Figure 54. Global Varicella Attenuated Live Vaccination Price (US$/Unit) by Type (2020-2031)
 Figure 55. Global Sales Market Share of Varicella Attenuated Live Vaccination by Application (2020-2031)
 Figure 56. Global Revenue Market Share of Varicella Attenuated Live Vaccination by Application (2020-2031)
 Figure 57. Global Varicella Attenuated Live Vaccination Price (US$/Unit) by Application (2020-2031)
 Figure 58. Varicella Attenuated Live Vaccination Value Chain
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano String

SIMILAR REPORTS

Global Varicella Attenuated Live Vaccine Market Research Report 2025
Varicella Virus Attenuated Live Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Varicella Virus Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Chickenpox Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Live Herpes Zoster Vaccine Market Research Report 2024
Global Varicella Live Vaccine Market Insights Forecast to 2030
Global Varicella Vaccination Market Research Report 2025
Global Live Attenuated Vaccine for Chickenpox Market Research Report 2025
Global Live Attenuated Varicella Vaccine Market Research Report 2025
Global Poultry Live Attenuated Vaccine Market Research Report 2024
Live Attenuated Herpes Zoster Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Chickenpox Varicella Vaccine Market
Live Attenuated Japanese Encephalitis Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Live Attenuated Vaccines for Pets Market Research Report 2025
Global Live Attenuated Polio Vaccine Market Research Report 2024
Global Varicella Vaccine Sales Market Report Competitive Analysis and Regional Opportunities 2025 2031
Global Live Attenuated Vaccine for Pig Market Research Report 2024
Live and Attenuated Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Live Attenuated Rotavirus Vaccine Market Research Report 2024
Global Nasal Spray Live Attenuated Vaccine Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions